Y33-64625-67954
2 vaccinations
2 coded responses
13 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 660 / KS
- Registered
- 2021-10-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-10-11
Registered in v-safe
-
2021-10-11
Dose 1 — Pfizer-BioNTech
- 2021-10-11
- 2021-10-14
- 2021-10-15
- 2021-10-16
- 2021-10-17
-
2021-10-18
Survey response — day 7, dose 1MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Sore throat, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-10-25
- 2021-11-01
-
2021-11-08
Dose 2 — Pfizer-BioNTech
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-12-01
-
2021-12-06
Survey response — day 28, dose 2MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: FairFree text: Cold symptoms. Runny nose, slight cough.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-11 | Pfizer-BioNTech | No |
| 2 | 2021-11-08 | Pfizer-BioNTech | No |
Free text
Release 10 — day 7, dose 1
Systemic reaction (other): Sore throat, runny nose
Release 10 — day 28, dose 2
Symptoms: Cold symptoms. Runny nose, slight cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release